NCT06065280: Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF Patients
- State
- Completed
- Phase
- No phase
- People
- 80 taking part
- Started
- 1 Nov 2022
- Primary completion
- 1 Dec 2024
- Arms
- Diabetic/HFrEF Group, Nondiabetic/HFrEF Group
- Results
- None posted
- 1 Nov 2022: Trial started
- 3 Oct 2023: Trial registered
- 30 Dec 2024: Trial completed